Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0009402 (
colorectal cancer
)
53,228
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Increasing evidence indicates that long non-coding RNAs (lncRNAs) are closely associated with the progression of human cancer, including
colorectal cancer
(
CRC
). A previous study suggested that lncRNA LINC01503 promotes squamous cell carcinoma progression. However, the function of LINC01503 in
CRC
has remained elusive. The present study indicated that LINC01503 was significantly upregulated in
CRC
tissues compared with that in adjacent normal tissues as detected by reverse transcription-quantitative polymerase chain reaction. It was demonstrated that knockdown of long intergenic non-protein coding RNA (LINC)01503 markedly inhibited the proliferation and invasion of
CRC
cells, whereas overexpression of LINC01503 had the opposite effects, as indicated by Cell Counting kit-8 and Transwell assays. Mechanistically, it was revealed that LINC01503 serves as a sponge for microRNA (miR)-4492, which targets
forkhead box K1
(
FOXK1
) in
CRC
cells. In addition, luciferase reporter assays demonstrated the direct binding of miR-4492 mimics to LINC01503 and to a sequence in the 3'-untranslated region of
FOXK1
. Furthermore, it was demonstrated that overexpression of LINC01503 reduced the availability of miR-4492 in
CRC
cells. Furthermore, miR-4492 mimics inhibited
FOXK1
expression, while simultaneous overexpression of LINC01503 abolished this effect. Finally, it was demonstrated that restoration of
FOXK1
abolished the inhibitory effect of LINC01503 knockdown on
CRC
cell proliferation and invasion. Taken together, the present results suggested that LINC01503 promotes
CRC
progression via acting as a competing endogenous RNA for miR-4492/
FOXK1
.
...
PMID:Long non-coding RNA LINC01503 promotes colorectal cancer cell proliferation and invasion by regulating miR-4492/FOXK1 signaling. 3054 44
The pathogenesis of
colorectal cancer
(
CRC
) is poorly understood. MicroRNA (miR)-32 upregulation in
CRC
tissues was previously reported, where it increased the proliferation, migration and invasion, and reduced apoptosis of
CRC
cells by inhibiting the expression of phosphatase and tensin homolog (PTEN). However, the mechanism underlying miR-32 upregulation remains unknown. miR-32 is an intronic miRNA located within intron 14 of the transmembrane protein 245 gene (TMEM245). The present study aimed to elucidate the biological pathways underlying miR-32 regulation in
CRC
. A truncated promoter containing the 5'-flanking region of TMEM245/miR-32 gene was constructed. The promoter region was analyzed by dual luciferase reporter assay in
CRC
cells. DNA pull-down assay and mass spectrometry (MS) were used to identify proteins binding to the core promoter. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and transcription factor (TF) analyses were used to identify the binding proteins. The -320 to -1 bp fragment of the 5'-flanking region exhibited the highest luciferase activity. The regions spanning -606 to -320 bp exhibited a significant decrease in luciferase activity, compared with the -320 to -1 bp fragment. DNA pull-down assay and MS revealed 403 potential miR-32 promoter binding proteins. GO and KEGG pathway analysis indicated that these proteins were involved in numerous physiological and biochemical processes, including 'structural molecule activity', 'RNA binding', 'small molecule metabolic process' and 'biogenesis'. Furthermore, TF analysis revealed 10 potential interacting TFs, including SMAD family member 1 (SMAD1), signal transducer and activator of transcription 1 (STAT1) and
forkhead box K1
(Foxk1). These results suggested that the core promoter region may be located within-320 to -1 bp of the 5'-flanking region of TMEM245/miR-32 gene, while the region from -606 to -320 bp may harbor repressive regulatory elements. The TFs SMAD1, STAT1 and Foxk1 may be involved in the transcriptional regulation of miR-32.
...
PMID:Analysis of the promoter region of the human miR-32 gene in colorectal cancer. 3088 96